HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Aβ1-40/Aβ1-42.

Abstract
A middle-aged male suffering from encephalopathy with cerebral amyloid angiopathy (CAA) with amyloid beta (Aβ) presented with initial symptoms of transient consciousness disturbance and left visual field photophobia. Lesions with aberrantly high signal on T2-weighted magnetic resonance imaging (MRI) of the brain appeared in the right temporal lobe posterior to the occipital lobe and spread to other areas. Brain biopsy revealed Aβ deposits in vascular walls and numerous diffuse plaques in parenchymal areas. Based on MRI findings, Initial corticosteroid therapy with beta methasone effectively improved the neurological symptoms of consciousness disturbance and motor deficits. After corticosteroid therapy was stopped at 4 weeks, recurrence occurred. Additional corticosteroids did not improve clinical symptoms and the patient progressed to a bed-ridden state with a severe consciousness disturbance. Notably, CSF Aβ1-42 and CSF Aβ1-40 decreased while the recurrent encephalopathy worsened. After intense deterioration, the patient became stable. CSF Aβ1-42 increased but remained at a very low level. This case of CAA encephalopathy with apolipoprotein E ϵ4/ϵ4 homozygosity showed Aβ deposits in vascular walls and numerous diffuse plaques in parenchymal areas. The clinical course suggests that reduction of CSF Aβ1-42 and Aβ1-40 might be related to clinical deterioration in cases of encephalopathy.
AuthorsMasaki Ikeda, Kimitoshi Hirayanagi, Motonobu Arai, Satoko Kakuda, Kouki Makioka, Natsumi Furuta, Eriko Takai, Hiroo Kasahara, Setsuki Tsukagoshi, Yukio Fujita, Masakuni Amari, Masamitsu Takatama, Yoichi Nakazato, Koichi Okamoto
JournalAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (Amyloid) Vol. 19 Issue 4 Pg. 186-90 (Dec 2012) ISSN: 1744-2818 [Electronic] England
PMID22994303 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Apolipoproteins E
  • Peptide Fragments
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (1-42)
Topics
  • Amyloid beta-Peptides (cerebrospinal fluid)
  • Apolipoproteins E (genetics)
  • Biopsy
  • Brain Diseases, Metabolic (complications, metabolism, pathology)
  • Cerebral Amyloid Angiopathy (complications, metabolism, pathology)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Occipital Lobe (metabolism, pathology)
  • Peptide Fragments (cerebrospinal fluid)
  • Plaque, Amyloid (cerebrospinal fluid, pathology)
  • Temporal Lobe (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: